CANF

Can-Fite BioPharma
CANF

Overview Fund Activity

12 hedge funds and large institutions have $465K invested in Can-Fite BioPharma in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
1
Virtu Financial
New York
$52K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$43K
3
Morgan Stanley
3
Morgan Stanley
New York
$311K
4
UBS Group
4
UBS Group
Switzerland
$7K

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$0
2
Wells Fargo
2
Wells Fargo
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$311K 338,275 +34,100 +11%
VF
2
Virtu Financial
New York
$52K 56,322 +56,322 New
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$43K 46,670 +46,670 New
Fifth Third Bancorp
4
Fifth Third Bancorp
Ohio
$28K 30,000 – –
Stifel Financial
5
Stifel Financial
Missouri
$11K 12,000 – –
UBS Group
6
UBS Group
Switzerland
$7K 7,521 +340 +5%
National Bank of Canada
7
National Bank of Canada
Quebec, Canada
$5K 6,000 – –
Citigroup
8
Citigroup
New York
$5K 5,535 – –
APA
9
American Portfolios Advisors
New York
$1.01K 1,100 – –
CAPTRUST Financial Advisors
10
CAPTRUST Financial Advisors
North Carolina
$1K 1,549 – –
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
$490 533 – –
TWC
12
TD Waterhouse Canada
Ontario, Canada
$233 203 – –
Citadel Advisors
13
Citadel Advisors
Florida
– – -11,333 Closed
Wells Fargo
14
Wells Fargo
California
– – -1,500 Closed
Bank of America
15
Bank of America
North Carolina
– – -366 Closed
CFGS
16
Concourse Financial Group Securities
Alabama
– – – –